SF
IHE icon

Synovus Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Synovus Financial’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-708
Closed -$31K – 1839
2020
Q1 		$31K Buy
+708
New +$35.7K ﹤0.01% 1239
2013
Q4 		– Sell
-1,893
Closed -$67K – 906
2013
Q3 		$67K Buy
1,893
+9
+0.5% +$317 ﹤0.01% 487
2013
Q2 		$63K Buy
+1,884
New +$62.6K ﹤0.01% 485

Other funds holding IHE

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Synovus Financial's IHE Position: Q2 2020 in Review

Synovus Financial sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2020, closing a stake of 708 shares — an estimated $31K sold.

Synovus Financial first reported a position in IHE in Q2 2013 and held it in 3 quarters. The position peaked at $67K in Q3 2013. 91 funds tracked by Wall St. Rank hold IHE as of Q2 2020.

  • Synovus Financial reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 708 iShares US Pharmaceuticals ETF shares in Q2 2020, an estimated $31K.
  • Synovus Financial first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 3 quarters.
  • Synovus Financial's iShares US Pharmaceuticals ETF position peaked at $67K in Q3 2013.
  • 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.